Aramark 경영진
경영진 기준 점검 4/4
Aramark CEO는 John Zillmer, Oct2019 에 임명되었습니다 의 임기는 6.83 년입니다. 총 연간 보상은 $14.54M, 9.1% 급여 및 90.9% 보너스(회사 주식 및 옵션 포함)로 구성됩니다. 는 $33.90M 가치에 해당하는 회사 주식의 0.23% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 6.5 년과 5.5 년입니다.
핵심 정보
John Zillmer
최고경영자
US$14.5m
총 보수
| CEO 급여 비율 | 9.11% |
| CEO 재임 기간 | 6.8yrs |
| CEO 지분 보유율 | 0.2% |
| 경영진 평균 재임 기간 | 6.5yrs |
| 이사회 평균 재임 기간 | 5.5yrs |
최근 경영진 업데이트
Recent updates
새로운 내러티브 • Jul 25
Hyperscale Data Center Ambitions Will Strain Margins And Limit Long-Term Upside
Catalysts About Aramark Aramark provides food, facilities and hospitality services to clients across education, healthcare, business, sports, entertainment and other customer locations worldwide. What are the underlying business or industry changes driving this perspective?
내러티브 업데이트 • Jul 24
ARMK: Data Center Contracts And Core Execution Will Shape Future Cash Flows
The analyst price target for Aramark has been revised higher as the fair value estimate moves from $58.25 to $59.44. Analysts point to rising confidence in the Nexus data center opportunity and recent upward price target revisions across the Street as key supports for their updated view.내러티브 업데이트 • Jun 29
ARMK: Data Center Builds And Nexus Platform Will Shape Future Cash Flows
Analysts increased their fair value estimate for Aramark to $58.25 from $56.63, citing a series of recent price target raises toward $65 to $70.50 that reflect growing confidence in the Nexus platform, tighter cost control through the middle of the P&L and the long-term potential of the data center services opportunity. Analyst Commentary Recent Street research on Aramark clusters around a more constructive view of the company’s growth and margin potential, particularly around the Nexus platform and the emerging data center services business.Seeking Alpha • Jun 27
Aramark: Demand Is Strong, And Nexus Is A New Growth Driver
Summary I am upgrading Aramark to buy as commercial momentum is now translating into visible revenue and margin improvement. ARMK’s organic revenue grew 12% in Q2 2026, with broad-based strength and >98% client retention, supporting a durable growth thesis. Nexus, targeting hyperscale AI data centers, offers a new, higher-margin growth driver not yet reflected in FY2026 guidance. Valuation at ~22x NTM PE is justified by structural growth drivers, with potential upside to ~$68–$85 per share by FY28–FY29. Read the full article on Seeking Alpha분석 기사 • Jun 16
Aramark (ARMK) Stock Could Be 4.3% Undervalued After School Menu Update
Aramark (ARMK) stock is in focus after Aramark Student Nutrition announced updated school menus for the 2026-2027 year, emphasizing ingredient transparency, removal of several additives, and closer alignment with regulatory trends. See our latest analysis for Aramark. The updated Aramark Student Nutrition menus land at a time when momentum in Aramark stock has been building, with a 90 day share price return of 32.62% and a year to date share price return of 48.17%, while total shareholder...내러티브 업데이트 • Jun 12
ARMK: Data Center Buildouts And Core Contracts Will Shape Future Cash Generation
Aramark's analyst price target has been updated from $55.25 to $56.63, reflecting analysts' focus on the company's expanding data center services and ongoing momentum in its core contracts as key factors in their revised assumptions. Analyst Commentary Recent research updates show a clear shift higher in valuation assumptions for Aramark, with multiple firms lifting their price targets into the mid to high US$50s and some reaching into the low US$60s.내러티브 업데이트 • May 29
ARMK: Data Center Contracts And Core Markets Will Shape Future Cash Generation
The analyst price target for Aramark has been raised from $52.63 to $55.25 as analysts factor in recent Q2 upside, indications of stronger FY26 growth, new data center opportunities, and continued momentum in core end markets. Analyst Commentary Recent research updates show a cluster of higher price targets for Aramark following the latest Q2 results and guidance commentary, with many analysts pointing to earnings momentum and new contract opportunities as key drivers for their revised views.내러티브 업데이트 • May 15
ARMK: Data Center Upside And Health Contract Will Support Future Free Cash Flow
Analysts lifted the Aramark price target by $5 to $52.63, citing solid Q2 results, expanding data center and hyperscaler multiservice opportunities, and broadly higher long term estimates across revenue, margins and future P/E assumptions. Analyst Commentary Recent research updates cluster around a common message that Aramark is executing well on Q2 priorities, with price targets moving higher on the back of solid earnings, a clearer data center opportunity and ongoing new business wins.내러티브 업데이트 • Apr 29
ARMK: Organic Wins And 2026 Health Contract Will Support Future Free Cash Flow
The analyst price target for Aramark is adjusted modestly higher to $47.63 from $47.16, with analysts pointing to steadier revenue growth assumptions, a slightly higher profit margin outlook, and recent positive research highlighting organic growth and new contract wins as support for the change. Analyst Commentary Recent research around Aramark centers on organic growth trends, contract wins and how these factors feed into valuation.내러티브 업데이트 • Apr 13
ARMK: Organic Wins And 2026 Health Contract Will Support Future Free Cash Flow
Aramark's analyst price target has inched higher, with a modest fair value adjustment to about $47.16 as analysts highlight stronger than expected organic growth trends, a new RWJ Barnabas Health contract scheduled to ramp up in 2026, and generally constructive sector views as key supports. Analyst Commentary Bullish analysts are generally constructive on Aramark, pointing to recent price target increases and renewed coverage with higher fair value estimates.내러티브 업데이트 • Mar 26
ARMK: New Contracts And Buybacks Will Support Future Free Cash Flow
Analysts have raised the implied fair value for Aramark by about $0.47 to $47.09, reflecting updated assumptions around revenue growth, profitability and future P/E in the context of a recent wave of higher $50 price targets across research reports. Analyst Commentary Recent research updates cluster around a US$50 price target, with several firms lifting their views in quick succession.내러티브 업데이트 • Mar 05
ARMK: Contract Wins And Buybacks Will Support Higher FY26 Cash Generation
Narrative Update Analysts have lifted their average price target on Aramark by about $3 to $50, citing stronger than expected organic growth and increased visibility from a new RWJ Barnabas Health contract, as well as broader optimism regarding revenue, EPS and free cash flow trends into 2026. Analyst Commentary Recent Street research on Aramark centers on higher price targets and fresh coverage, with most of the discussion tied to organic growth trends, contract wins and expectations for earnings and cash flow through 2026.내러티브 업데이트 • Feb 18
ARMK: Contract Wins And Buybacks Will Support Stronger FY26 Earnings Delivery
Analysts have lifted their average Aramark price target from about $44.60 to roughly $46.63. The updated views factor in recent organic growth trends and expectations for future contract contributions and earnings power.내러티브 업데이트 • Feb 03
ARMK: Contract Timing Delays Will Support Stronger FY26 Earnings Delivery
Narrative Update on Aramark Analysts have trimmed their Aramark price target to US$44 from US$49, citing a shift in expected revenue timing as client driven delays in new contract starts across Corrections, Workplace Experience, and Healthcare push more of the projected contribution into FY26. They continue to model a similar long term P/E and margin profile.내러티브 업데이트 • Jan 19
ARMK: Contract Timing Delays Will Create FY26 Margin Upside Scenario
Analysts recently trimmed their Aramark price target to $44 from $49, pointing to what they describe as strong underlying business momentum, but also to client driven timing delays on new contract starts that are expected to shift some revenue and margin impact into FY26. Analyst Commentary Bullish Takeaways Bullish analysts see the lower US$44 price target as reflecting updated timing rather than a change in their view of Aramark’s underlying business momentum.분석 기사 • Jan 06
Is Aramark (NYSE:ARMK) Worth US$38.0 Based On Its Intrinsic Value?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Aramark fair value estimate is US$30.02 Current share price of...내러티브 업데이트 • Jan 04
ARMK: Delayed Contract Ramps Will Drive Stronger Earnings Setup In Fiscal 2026
Analysts have modestly reduced their price target on Aramark to approximately $44 from about $49, citing strong underlying business momentum but near term revenue and earnings pressure from client driven timing delays in new contract starts, which are now expected to shift more meaningfully into FY26. Analyst Commentary Bullish Takeaways Bullish analysts highlight that underlying business momentum remains solid across key operating segments, supporting confidence in the company’s long term growth trajectory despite near term volatility.내러티브 업데이트 • Dec 18
ARMK: Delayed Contract Starts Will Support Stronger Earnings Momentum In Fiscal 2026
Analysts have trimmed their price target on Aramark to $44 from $49, reflecting expectations for strong underlying momentum but a near term zig zag in revenue and margins as client driven contract start delays shift more growth into FY26. Analyst Commentary Street research indicates that the recent price target reduction reflects adjustments to the timing of expected growth rather than a reset of the long term thesis.내러티브 업데이트 • Dec 04
ARMK: Delayed Contract Starts Will Shift Earnings Momentum Toward Fiscal 2026
Analysts have modestly raised their Aramark price target to approximately $44.60 per share from about $44.43, citing strong underlying business momentum despite near term revenue and earnings pressure from client driven delays in new contract starts, which are now expected to shift growth into FY26. Analyst Commentary Recent Street research highlights a mixed, but generally constructive, view on Aramark, with analysts fine tuning their expectations to reflect both the strength of the core business and the impact of timing related revenue shifts.분석 기사 • Nov 20
Earnings Miss: Aramark Missed EPS By 19% And Analysts Are Revising Their Forecasts
Aramark ( NYSE:ARMK ) shareholders are probably feeling a little disappointed, since its shares fell 4.6% to US$36.73...내러티브 업데이트 • Nov 19
ARMK: Delayed Contract Starts Will Drive Revenue Expansion Beyond Fiscal 2025
Aramark's analyst price target has been revised downward from $45.10 to $44.43, as analysts factor in strong underlying business momentum while adjusting for delays in revenue and earnings due to client-driven timing in new contract starts. Analyst Commentary Analyst perspectives on Aramark reflect a mix of optimism about core business trends and caution around near-term uncertainty driven by client timing.분석 기사 • Oct 01
What Is Aramark's (NYSE:ARMK) Share Price Doing?
Aramark ( NYSE:ARMK ) saw significant share price movement during recent months on the NYSE, rising to highs of...내러티브 업데이트 • Sep 03
Sports, Education And Healthcare Wins Will Expand Global Reach
Aramark’s fair value estimate was slightly reduced as a result of a deteriorating net profit margin and an increased future P/E, indicating weaker profitability and pricier valuation. What's in the News Aramark expanded its presence in NCAA collegiate sports by delivering customized hospitality experiences at over 30 football stadiums and secured new partnerships with Arizona State University and the University of Nebraska.Seeking Alpha • Apr 28
Aramark Is A 'BUY', But With Some Details (Rating Upgrade)
Summary I initially invested in Aramark, saw a 50%+ gain, then switched to Sodexo, which has shown potential for further growth. Despite Aramark's recent 14% decline, I see a long-term investment opportunity, especially with Sodexo's potential acquisition interest. Aramark's strong performance, revenue growth, and improved margins make it a compelling buy, with an updated price target of $40/share. While Aramark is a "BUY," Sodexo remains a superior choice due to better credit rating, yield, and overall fundamentals. Read the full article on Seeking AlphaSeeking Alpha • Feb 08
Aramark: Rating Downgrade To Hold As I See Risk To The Company Meeting FY25 Guidance
Summary I downgraded ARMK from buy to hold due to 1Q25 performance and risks of missing FY25 guidance. Weak US organic growth and onboarding delays in Education and Healthcare segments pose significant risks to achieving FY25 targets. Strong international growth is promising but may not offset US weaknesses and potential FX headwinds. ARMK's valuation could drop significantly if growth slows, with potential de-rating to low teens forward earnings multiple. Read the full article on Seeking AlphaSeeking Alpha • Nov 22
Aramark: Robust FY25 Outlook
Summary I reiterate a buy rating for ARMK due to its robust FY25 outlook, driven by organic growth and a strengthened balance sheet. Aramark's 4Q24 earnings were in line with expectations, with revenue growth driven by organic means and strong pipeline momentum. The launch of Avendra, ARMK's global GPO, is expected to enhance margins by leveraging scale for better purchasing deals. ARMK's improved balance sheet allows for increased shareholder returns through dividends and a $500 million share buyback program. Read the full article on Seeking AlphaCEO 보수 분석
| 날짜 | 총 보수 | 급여 | 회사 수익 |
|---|---|---|---|
| Apr 03 2026 | n/a | n/a | US$357m |
| Jan 02 2026 | n/a | n/a | US$317m |
| Oct 03 2025 | US$15m | US$1m | US$326m |
| Jun 27 2025 | n/a | n/a | US$362m |
| Mar 28 2025 | n/a | n/a | US$348m |
| Dec 27 2024 | n/a | n/a | US$340m |
| Sep 27 2024 | US$19m | US$1m | US$263m |
| Jun 28 2024 | n/a | n/a | US$248m |
| Mar 29 2024 | n/a | n/a | US$477m |
| Dec 29 2023 | n/a | n/a | US$438m |
| Sep 29 2023 | US$13m | US$1m | US$448m |
| Jun 30 2023 | n/a | n/a | US$415m |
| Mar 31 2023 | n/a | n/a | US$169m |
| Dec 30 2022 | n/a | n/a | US$190m |
| Sep 30 2022 | US$13m | US$1m | US$39m |
| Jul 01 2022 | n/a | n/a | US$154m |
| Apr 01 2022 | n/a | n/a | US$146m |
| Dec 31 2021 | n/a | n/a | US$33m |
| Oct 01 2021 | US$5m | US$1m | -US$91m |
| Jul 02 2021 | n/a | n/a | -US$275m |
| Apr 02 2021 | n/a | n/a | -US$564m |
| Jan 01 2021 | n/a | n/a | -US$689m |
| Oct 02 2020 | US$27m | US$1m | -US$462m |
보상 대 시장: John의 총 보수(USD14.54M)는 US 시장에서 비슷한 규모 기업의 평균(USD14.56M) 수준입니다.
보상과 수익: John의 보상은 지난 1년 동안 회사 실적과 일치했습니다.
CEO
John Zillmer (71 yo)
6.8yrs
재임 기간
US$14,542,376
보수
Mr. John J. Zillmer serves as an Industrial Advisor at CVC Capital Partners plc. Mr. Zillmer served as an Advisor at CVC Capital Partners since 2014. He specializes in Chemical Distribution, Waste Manageme...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO & Director | 6.8yrs | US$14.54m | 0.23% $ 33.9m | |
| Executive VP & CFO | 9.8yrs | US$3.31m | 0.023% $ 3.4m | |
| Executive VP & General Counsel | 7.4yrs | US$3.32m | 0.030% $ 4.4m | |
| Executive VP & Chief Human Resources Officer | 3.6yrs | US$3.11m | 0.031% $ 4.6m | |
| Chief Operating Officer of U.S. Food & Facilities | 11.6yrs | US$4.00m | 0.14% $ 21.1m | |
| President | no data | 데이터 없음 | 데이터 없음 | |
| Chief Operating Officer of International | 6.5yrs | 데이터 없음 | 데이터 없음 | |
| Senior VP | 5.1yrs | 데이터 없음 | 0.0094% $ 1.4m | |
| Investor Relations & Corporate Affairs Executive | no data | 데이터 없음 | 데이터 없음 | |
| President of Sports & Entertainment | 6.5yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Strategic Communications & Corporate Affairs | no data | 데이터 없음 | 데이터 없음 | |
| Executive Vice President of Global Supply Chain & Group Purchasing Organizations | 2.9yrs | 데이터 없음 | 데이터 없음 |
6.5yrs
평균 재임 기간
53.5yo
평균 나이
경험이 풍부한 관리: ARMK의 경영진은 노련하고 경험이 풍부합니다(평균 재임 6.5 년).
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO & Director | 6.8yrs | US$14.54m | 0.23% $ 33.9m | |
| Non-Executive Independent Chairman | 12.8yrs | US$527.30k | 0.011% $ 1.6m | |
| Independent Director | 1.7yrs | US$305.00k | 0.000050% $ 7.5k | |
| Independent Director | 6.8yrs | US$333.38k | 0.018% $ 2.7m | |
| Independent Director | 5.5yrs | US$313.38k | 0.014% $ 2.0m | |
| Independent Director | 3.5yrs | US$341.81k | 0.0021% $ 314.8k | |
| Independent Director | 6.6yrs | US$336.76k | 0.0047% $ 707.2k | |
| Independent Director | 6.8yrs | US$313.70k | 0.012% $ 1.8m | |
| Independent Director | 2.6yrs | US$313.38k | 0.0062% $ 929.5k | |
| Independent Director | 4.5yrs | US$313.38k | 0.011% $ 1.7m | |
| Independent Director | 4.5yrs | US$303.50k | 0.011% $ 1.7m |
5.5yrs
평균 재임 기간
68yo
평균 나이
경험이 풍부한 이사회: ARMK의 이사회는 경험이 있음으로 간주됩니다(평균 재임 5.5 년).
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/08/04 23:17 |
| 종가 | 2026/08/04 00:00 |
| 수익 | 2026/04/03 |
| 연간 수익 | 2025/10/03 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Aramark는 23명의 분석가가 다루고 있습니다. 이 중 16명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Andrew Wittmann | Baird |
| Manav Patnaik | Barclays |
| Stuart Gordon | Berenberg |